Cardiac safety of drugs targeting IL-5 (mepolizumab, reslizumab, or benralizumab) compared to omalizumab
Latest Information Update: 23 Dec 2020
At a glance
- Drugs Benralizumab (Primary) ; Mepolizumab (Primary) ; Reslizumab (Primary) ; Omalizumab
- Indications Asthma
- Focus Adverse reactions
- 23 Dec 2020 New trial record